[BOOK][B] Drug Safety
NSB Rawson - 2016 - books.google.com
With" Big Pharma" garnering an increasing number of negative headlines due to reports of
adverse drug reactions and a surge in prescription drug addiction and overdose deaths …
adverse drug reactions and a surge in prescription drug addiction and overdose deaths …
Canadian and US drug approval times and safety considerations
NSB Rawson, KI Kaitin - Annals of Pharmacotherapy, 2003 - journals.sagepub.com
Background Approval times of new drugs are frequently longer in Canada than in the US,
but it has been argued that reducing approval times might lead to unsafe drugs receiving …
but it has been argued that reducing approval times might lead to unsafe drugs receiving …
Timeliness of review and approval of new drugs in Canada from 1999 through 2001: is progress being made?
NSB Rawson - Clinical therapeutics, 2003 - Elsevier
Background: The median time to approval of new drugs in Canada decreased considerably
in the mid-1990s, although it continued to be longer than in such countries as Australia …
in the mid-1990s, although it continued to be longer than in such countries as Australia …
[CITATION][C] Issues in the approval of, access to, and post‐marketing follow‐up of new drugs in Canada: a personal viewpoint
NSB Rawson - Pharmacoepidemiology and Drug Safety, 2002 - Wiley Online Library
Previous ISPE commentaries have described the difficulties that countries such as Thailand,
1 Iran2 and Korea3 face in trying to achieve an adequate postmarketing surveillance …
1 Iran2 and Korea3 face in trying to achieve an adequate postmarketing surveillance …
[CITATION][C] INTERNATIONAL BIOPHARMACEUTICAL ASSOCIATION PUBLICATION
O Tobun - Population